High-intensity focused ultrasound (HIFU) is an increasingly used, locally ablative therapy option in localized prostate cancer (PCa). Multiparametric MRI (mpMRI) is currently used for tumor ...

Nuclear medicine has undergone a remarkable transformation, with both diagnostic and therapeutic applications expanding at an unprecedented pace. This progress is rooted in fundamental discoveries by ...

Radiotheranostics refers to dual diagnostic–therapeutic capacity that allows for precision medicine at an unprecedented level, reducing collateral toxicity and improving patient outcomes ([1][1]). In ...

Prostate-specific membrane antigen (PSMA) is a promising target in prostate cancer. Recently, we started the first-in-human treatment with an α-radionuclide–labeled PSMA ligand. Although the case ...

Intense overexpression of the cell-surface peptidase prostate-specific membrane antigen (PSMA) in most primary and metastatic prostate cancers, as well as a positive correlation between PSMA and ...

Journal of Nuclear Medicine May 2025, jnumed.125.269533; DOI: https://doi.org/10.2967/jnumed.125.269533 ...

Journal of Nuclear Medicine November 2025, jnumed.125.270481; DOI: https://doi.org/10.2967/jnumed.125.270481 ...

Journal of Nuclear Medicine November 2025, jnumed.125.270710; DOI: https://doi.org/10.2967/jnumed.125.270710 ...

Journal of Nuclear Medicine November 2025, jnumed.125.269782; DOI: https://doi.org/10.2967/jnumed.125.269782 ...

Journal of Nuclear Medicine November 2025, jnumed.125.270404; DOI: https://doi.org/10.2967/jnumed.125.270404 ...

This retrospective study was approved by the local institutional review board. PSMA PET/CT was performed on more than 2,000 men with prostate carcinoma at the Department of Nuclear Medicine, ...

For staging of cancer patients, 18F-FDG PET imaging has been applied for about a decade. It is generally accepted that imaging the metabolic activity of tumor tissue provides more sensitive and more ...